Publications by authors named "Greg Duke"

Claim this Profile
F
FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models.
Marie O'Farrell, Greg Duke, Richard Crowley, Douglas Buckley, Eduardo B Martins

Sci Rep· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Production of Cytomegalovirus Dense Bodies by Scalable Bioprocess Methods Maintains Immunogenicity and Improves Neutralizing Antibody Titers.
Kirsten Schneider-Ohrum, Corinne Cayatte, Yi Liu, Zhaoti Wang, Alivelu Irrinki, Greg Duke

J Virol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets.
Amorsolo L Suguitan, Josephine McAuliffe, Kimberly L Mills, Hong Jin, Greg Duke

PLoS Med· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines.
Thomas C Heineman, Mark Schleiss, David I Bernstein, Richard R Spaete, Lihan Yan, Greg Duke

J Infect Dis· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis